ADPT logo

ADPT Depreciation & Amortization

Annual D&A:

$19.26M-$2.98M(-13.38%)
December 31, 2024

Summary

  • As of today, ADPT annual D&A is $19.26 million, with the most recent change of -$2.98 million (-13.38%) on December 31, 2024.
  • During the last 3 years, ADPT annual D&A has risen by +$5.30 million (+38.01%).
  • ADPT annual D&A is now -13.38% below its all-time high of $22.23 million, reached on December 31, 2023.

Performance

ADPT Depreciation & Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTincome statement metrics

Quarterly D&A:

$4.41M-$97.00K(-2.15%)
September 30, 2025

Summary

  • As of today, ADPT quarterly D&A is $4.41 million, with the most recent change of -$97.00 thousand (-2.15%) on September 30, 2025.
  • Over the past year, ADPT quarterly D&A has dropped by -$186.00 thousand (-4.05%).
  • ADPT quarterly D&A is now -42.18% below its all-time high of $7.62 million, reached on September 30, 2023.

Performance

ADPT Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTincome statement metrics

TTM D&A:

$18.09M-$186.00K(-1.02%)
September 30, 2025

Summary

  • As of today, ADPT TTM D&A is $18.09 million, with the most recent change of -$186.00 thousand (-1.02%) on September 30, 2025.
  • Over the past year, ADPT TTM D&A has dropped by -$3.54 million (-16.38%).
  • ADPT TTM D&A is now -38.52% below its all-time high of $29.42 million, reached on September 30, 2023.

Performance

ADPT TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTincome statement metrics

ADPT Depreciation & Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-13.4%-4.0%-16.4%
3Y3 Years+38.0%-38.9%-34.6%
5Y5 Years+147.2%+46.0%+73.7%

ADPT Depreciation & Amortization Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-13.4%+38.0%-42.2%at low-38.5%at low
5Y5-Year-13.4%+147.2%-42.2%+46.0%-38.5%+73.7%
All-TimeAll-Time-13.4%+232.2%-42.2%+203.6%-38.5%+1146.5%

ADPT Depreciation & Amortization History

DateAnnualQuarterlyTTM
Sep 2025
-
$4.41M(-2.2%)
$18.09M(-1.0%)
Jun 2025
-
$4.50M(-4.8%)
$18.27M(-2.7%)
Mar 2025
-
$4.73M(+6.4%)
$18.77M(-2.5%)
Dec 2024
$19.26M(-13.4%)
$4.45M(-3.1%)
$19.26M(-11.0%)
Sep 2024
-
$4.59M(-8.2%)
$21.63M(-12.3%)
Jun 2024
-
$5.00M(-4.0%)
$24.66M(-9.1%)
Mar 2024
-
$5.21M(-23.6%)
$27.14M(-6.9%)
Dec 2023
$22.23M(+6.3%)
$6.82M(-10.5%)
$29.15M(-0.9%)
Sep 2023
-
$7.62M(+1.8%)
$29.42M(+1.4%)
Jun 2023
-
$7.48M(+3.5%)
$29.01M(+1.7%)
Mar 2023
-
$7.23M(+1.9%)
$28.53M(+1.4%)
Dec 2022
$20.92M(+49.9%)
$7.09M(-1.7%)
$28.15M(+1.7%)
Sep 2022
-
$7.21M(+3.0%)
$27.68M(+7.4%)
Jun 2022
-
$7.00M(+2.2%)
$25.76M(+10.0%)
Mar 2022
-
$6.85M(+3.5%)
$23.43M(+11.7%)
DateAnnualQuarterlyTTM
Dec 2021
$13.95M(+64.7%)
$6.62M(+24.9%)
$20.98M(+18.1%)
Sep 2021
-
$5.30M(+13.6%)
$17.76M(+14.7%)
Jun 2021
-
$4.66M(+5.9%)
$15.48M(+14.4%)
Mar 2021
-
$4.40M(+29.5%)
$13.53M(+15.3%)
Dec 2020
$8.47M(+8.7%)
$3.40M(+12.7%)
$11.74M(+12.7%)
Sep 2020
-
$3.02M(+11.3%)
$10.41M(+10.1%)
Jun 2020
-
$2.71M(+3.9%)
$9.46M(+9.8%)
Mar 2020
-
$2.61M(+25.7%)
$8.62M(+10.6%)
Dec 2019
$7.79M(+29.8%)
$2.08M(+0.6%)
$7.79M(+36.3%)
Sep 2019
-
$2.06M(+10.3%)
$5.72M(+56.5%)
Jun 2019
-
$1.87M(+4.9%)
$3.65M(+104.9%)
Mar 2019
-
$1.78M(+22.9%)
$1.78M(+22.9%)
Dec 2018
$6.00M(+3.5%)
-
-
Mar 2018
-
$1.45M
$1.45M
Dec 2017
$5.80M
-
-

FAQ

  • What is Adaptive Biotechnologies Corporation annual D&A?
  • What is the all-time high annual D&A for Adaptive Biotechnologies Corporation?
  • What is Adaptive Biotechnologies Corporation annual D&A year-on-year change?
  • What is Adaptive Biotechnologies Corporation quarterly D&A?
  • What is the all-time high quarterly D&A for Adaptive Biotechnologies Corporation?
  • What is Adaptive Biotechnologies Corporation quarterly D&A year-on-year change?
  • What is Adaptive Biotechnologies Corporation TTM D&A?
  • What is the all-time high TTM D&A for Adaptive Biotechnologies Corporation?
  • What is Adaptive Biotechnologies Corporation TTM D&A year-on-year change?

What is Adaptive Biotechnologies Corporation annual D&A?

The current annual D&A of ADPT is $19.26M

What is the all-time high annual D&A for Adaptive Biotechnologies Corporation?

Adaptive Biotechnologies Corporation all-time high annual D&A is $22.23M

What is Adaptive Biotechnologies Corporation annual D&A year-on-year change?

Over the past year, ADPT annual D&A has changed by -$2.98M (-13.38%)

What is Adaptive Biotechnologies Corporation quarterly D&A?

The current quarterly D&A of ADPT is $4.41M

What is the all-time high quarterly D&A for Adaptive Biotechnologies Corporation?

Adaptive Biotechnologies Corporation all-time high quarterly D&A is $7.62M

What is Adaptive Biotechnologies Corporation quarterly D&A year-on-year change?

Over the past year, ADPT quarterly D&A has changed by -$186.00K (-4.05%)

What is Adaptive Biotechnologies Corporation TTM D&A?

The current TTM D&A of ADPT is $18.09M

What is the all-time high TTM D&A for Adaptive Biotechnologies Corporation?

Adaptive Biotechnologies Corporation all-time high TTM D&A is $29.42M

What is Adaptive Biotechnologies Corporation TTM D&A year-on-year change?

Over the past year, ADPT TTM D&A has changed by -$3.54M (-16.38%)
On this page